Vaxcyte Inc — Quarterly Cash Flow (NASDAQ:PCVX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 3.56 B3.51 B3.38 B3.31 B3.17 B3 B Total liabilities 142.11 M205.5 M178.08 M234.03 M278.72 M317.21 M Total equity 3.42 B3.31 B3.2 B3.07 B2.89 B2.69 B Total liabilities & shareholders' equities 3.56 B3.51 B3.38 B3.31 B3.17 B3 B Total debt —————— Net debt ——————

ニュース

BTIGがVaxcyteの目標株価を89ドルに引き上げ、ワクチンの幅広いカバー範囲を評価

BTIG raises Vaxcyte price target to $89 on vaccine breadth edge

Leerinkがワクチンパイプライン拡大を受けてVaxcyteの目標株価を引き上げ

Leerink raises Vaxcyte stock price target on vaccine pipeline expansion

Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript

肺炎球菌ワクチンの重要データ発表を控えVaxcyte決算に注目集まる

Ovintiv to Report Q4 Earnings: What's in Store for the Stock?

Vaxcyte社、6億3250万ドルの普通株式公募を完了

Vaxcyte closes $632.5 million public offering of common stock

Vaxcyte社、5億5000万ドルの普通株式公募を価格決定

Vaxcyte prices $550 million public offering of common stock

Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance